Eloxx Pharmaceuticals Inc. Stock News

If you want to know who really controls Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX), then you'll have to look at the...

Q4 2019 Eloxx Pharmaceuticals Inc Earnings Call

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2)BELLUS Health Inc (NASDAQ: BLU)Down In The Dumps (Biote

Shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) have earned a consensus rating of “Buy” from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have ra

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 2) BELLUS Health Inc (NASDAQ:...

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) * Athersys Inc (NASDAQ: ATHX) * Forty Seven Inc (NA

Q4 2019 Eloxx Pharmaceuticals Inc Earnings Call

Eloxx Pharmaceuticals, Inc., (ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by no

Barclays PLC grew its stake in shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) by 93.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchang

Headlines about Eloxx Pharmaceuticals (OTCMKTS:ELOX) have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo...

Eloxx Pharmaceuticals (OTCMKTS:ELOX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The

Eloxx Pharmaceuticals (OTCMKTS:ELOX) had its target price decreased by Citigroup from $31.00 to $11.00 in a research note issued to investors on Monday, The Fly reports. The firm currently has a “ne

With the outbreak of the coronavirus, volatility has become a seemingly ever-present facet of the stock market. Since the end of February, the major U.S. indexes have experienced violent swings in eit

HC Wainwright restated their neutral rating on shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) in a research report sent to investors on Friday morning, The Fly reports. The brokerage currently has a $